Targeted Therapy and Drug Development focus on designing highly specific drugs that attack cancer cells without damaging healthy tissues. This improves treatment precision and patient survival rates.
It includes drug discovery, molecular targeting, and pharmaceutical development for oncology applications.
Several specialized areas are studied within Targeted Therapy, including:
• Small Molecule Inhibitors
• Tyrosine Kinase Inhibitors
• Monoclonal Antibodies
• Drug Resistance Mechanisms
• Oncology Drug Discovery
• Preclinical Drug Testing
• Clinical Trials in Oncology
• Molecular Target Identification